Radiopraxis, Table of Contents Radiopraxis 2021; 14(01): E1-E14DOI: 10.1055/a-1337-5521 CPD–Fortbildung Konventionelle nuklearmedizinische Bildgebung bei Hyperparathyreoidismus Simone Schenke , Michael Zimny , Michael C. KreißlRecommend Article Abstract Buy Article Full Text References Literatur 1 Sheu-Grabellus S-Y, Schmid KW. Pathologie der Nebenschilddrüse. Pathologe 2015; 36: 229-236 2 Noda S, Onoda N, Kashiwagi S. et al. Strategy of operative treatment of hyperparathyroidism using US scan and (99 m) Tc-MIBI SPECT/CT. Endocr J 2014; 61: 225-230 3 Huppert BJ. Reading CC. Parathyroid sonography: imaging and intervention. – PubMed – NCBI. Im Internet (Stand: 23.07.2020): https://www.ncbi.nlm.nih.gov/pubmed/?term=Huppert+Parathyroid+sonography%3A+imaging+and+intervention 4 Schlosser K, Wirowski D. Primärer Hyperparathyreoidismus – Teil 1: Epidemiologie, Anatomie und Symptomatik. Allg Viszeralchir Up2date 2013; 1: 23-26 5 Kedarisetty S, Fundakowski C, Ramakrishnan K. et al. Clinical value of Tc99 m-MIBI SPECT/CT versus 4 D-CT or US in management of patients with hyperparathyroidism. Ear Nose Throat J 2019; 98: 149-157 6 Guilmette J, Sadow PM. Parathyroid pathology. Surg Pathol Clin 2019; 12: 1007-1019 7 Schlosser K, Wirowski D. Primärer Hyperparathyreoidismus – Teil 2: Diagnostisches und therapeutisches Vorgehen. Allg Viszeralchir Up2date 2013; 1: 39-56 8 Zeng M, Liu W, Zha X. et al. 99 mTc-MIBI SPECT/CT imaging had high sensitivity in accurate localization of parathyroids before parathyroidectomy for patients with secondary hyperparathyroidism. Ren Fail 2019; 41: 885-892 9 Palestro CJ, Tomas MB, Tronco GG. Radionuclide imaging of the parathyroid glands. Semin Nucl Med 2005; 35: 266-276 10 Cheung K, Wang TS, Farrokhyar F. et al. A meta-analysis of preoperative localization techniques for patients with primary hyperparathyroidism. Ann Surg Oncol 2012; 19: 577-583 11 Rager O, Radojewski P, Dumont RA. et al. Radioisotope imaging for discriminating benign from malignant cytologically indeterminate thyroid nodules. Gland Surg 2019; 8: S118-S125 12 Arbab AS, Koizumi K, Toyama K. et al. Uptake of technetium-99 m-tetrofosmin, technetium-99 m-MIBI and thallium-201 in tumor cell lines. J Nucl Med 1996; 37: 1551-1556 13 Schmidt M, Schenke S. Update 2019 zur MIBI-Szintigrafie bei hypofunktionellen Schilddrüsenknoten. Nuklearmediziner 2019; 42: 174-182 14 Treglia G, Sadeghi R, Schalin-Jäntti C. et al. Detection rate of (99 m) Tc-MIBI single photon emission computed tomography (SPECT)/CT in preoperative planning for patients with primary hyperparathyroidism: A meta-analysis. Head Neck 2016; 38 : (Suppl. 01): E2159-2172 15 Taillefer R, Boucher Y, Potvin C. et al. Detection and localization of parathyroid adenomas in patients with hyperparathyroidism using a single radionuclide imaging procedure with technetium-99 m-sestamibi (double-phase study). J Nucl Med 1992; 33: 1801-1807 16 Xue J, Liu Y. , ji T. Comparison between technetium-99 m methoxyisobutylisonitrile scintigraphy and ultrasound in the diagnosis of parathyroid adenoma and parathyroid hyperplasia. Nucl Med Commun 2018; 39: 1129-1137 17 Sharma J, Mazzaglia P, Milas M. et al. Radionuclide imaging for hyperparathyroidism (HPT): which is the best technetium-99 m sestamibi modality? Surgery. 2006; 140: 856-863 ; discussion 863-865 18 Coakley AJ, Kettle AG, Wells CP. et al. 99Tcm sestamibi-a new agent for parathyroid imaging. Nucl Med Commun 1989; 10: 791-794 19 Bekanntmachung der aktualisierten diagnostischen Referenzwerte für nuklearmedizinische Untersuchungen. Bundesamt für Strahlenschutz; 2012: Im Internet (Stand: 23.07.2020): https://www.bfs.de/DE/themen/ion/anwendung-medizin/diagnostik/referenzwerte/referenzwerte_node.html 20 Hindié E, Ugur O, Fuster D. et al. 2009 EANM parathyroid guidelines. Eur J Nucl Med Mol Imaging 2009; 36: 1201-1216 21 Wong KK, Fig LM, Gross MD. et al. Parathyroid adenoma localization with 99 mTc-sestamibi SPECT/CT: a meta-analysis. Nucl Med Commun 2015; 36: 363-375 22 Kushchayeva YS, Tella SH, Kushchayev SV. et al. Comparison of hyperparathyroidism types and utility of dual radiopharmaceutical acquisition with Tc99 m sestamibi and 123I for localization of rapid washout parathyroid adenomas. Osteoporos Int 2019; 30: 1051-1057 23 Maccora D, Rizzo V, Fortini D. et al. Parathyroid scintigraphy in primary hyperparathyroidism: comparison between double-phase and subtraction techniques and possible affecting factors. J Endocrinol Invest 2019; 42: 889-895 24 Mihai R, Simon D, Hellman P. Imaging for primary hyperparathyroidism-an evidence-based analysis. Langenbecks Arch Surg 2009; 394: 765-784 25 Mshelia DS, Hatutale AN, Mokgoro NP. et al. Correlation between serum calcium levels and dual-phase (99 m)Tcsestamibi parathyroid scintigraphy in primary hyperparathyroidism. Clin Physiol Funct Imaging 2012; 32: 19-24 26 Silov G, Ozdal A, Erdoğan Z. et al. The relationship between technetium-99 m-methoxyisobutyl isonitrile parathyroid scintigraphy and hormonal and biochemical markers in suspicion of primary hyperparathyroidism. Mol Imaging Radionucl Ther 2013; 22: 8-13 27 Jorna FH, Hollema H, Hendrikse HN. et al. P-gp and MRP1 expression in parathyroid tumors related to histology, weight and (99 m)Tc-sestamibi imaging results. Exp Clin Endocrinol Diabetes 2009; 117: 406-412 28 Cordes M, Dworak O, Papadopoulos T. et al. MIBI scintigraphy of parathyroid adenomas: correlation with biochemical and histological markers. Endocr Res 2018; 43: 141-148 29 Calva-Cerqueira D, Smith BJ, Hostetler ML. et al. Minimally invasive parathyroidectomy and preoperative MIBI scans: correlation of gland weight and preoperative PTH. J Am Coll Surg 2007; 205: S38-44 30 Hassler S, Ben-Sellem D, Hubele F. et al. Dual-isotope 99 mTc-MIBI/123I parathyroid scintigraphy in primary hyperparathyroidism: comparison of subtraction SPECT/CT and pinhole planar scan. Clin Nucl Med 2014; 39: 32-36 31 Gayed IW, Kim EE, Broussard WF. et al. The value of 99 mTcsestamibi SPECT/CT over conventional SPECT in the evaluation of parathyroid adenomas or hyperplasia. J Nucl Med 2005; 46: 248-252 32 Neumann DR, Obuchowski NA, Difilippo FP. Preoperative 123I/99 mTc-sestamibi subtraction SPECT and SPECT/CT in primary hyperparathyroidism. J Nucl Med 2008; 49: 2012-2017 33 Ozderya A, Temizkan S, Gul AE. et al. Biochemical and pathologic factors affecting technetium-99 m-methoxyisobutylisonitrile imaging results in patients with primary hyperparathyroidism. Ann Nucl Med 2018; 32: 250-255 34 Aller SG, Yu J, Ward A. Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding. Science 2009; 232: 1718-1722 35 Yamaguchi S, Yachiku S, Hashimoto H. Relation between technetium 99 m-methoxyisobutylisonitrile accumulation and multidrug resistance protein in the parathyroid glands. Wold J Surg 2002; : 29-34 36 Kao A, Shiau Y-C, Tsai S-C. et al. Technetium-99 m methoxyisobutylisonitrile imaging for parathyroid adenoma: relationship to P-glycoprotein or multidrug resistancerelated protein expression. Eur J Nucl Med Mol Imaging 2002; 29: 1012-1015 37 Sun SS, Shiau YC, Lin CC. et al. Correlation between P-glycoprotein (P-gp) expression in parathyroid and Tc-99 m MIBI parathyroid image findings. Nucl Med Biol 2001; 28: 929-933 38 Ruda JM, Hollenbeak CS, Stack BC. A systematic review of the diagnosis and treatment of primary hyperparathyroidism from 1995 to 2003. Otolaryngol Head Neck Surg 2005; 132: 359-372 39 Caldarella C, Treglia G, Pontecorvi A. et al. Diagnostic performance of planar scintigraphy using 99 mTc-MIBI in patients with secondary hyperparathyroidism: a meta-analysis. Ann Nucl Med 2012; 26: 794-803 40 Nichols KJ, Tronco GG, Palestro CJ. Influence of multigland parathyroid disease on 99 mTc-Sestamibi SPECT/CT. Clin Nucl Med 2016; 41: 282-288 41 Takebayashi S, Hidai H, Chiba T. et al. Hyperfunctional parathyroid glands with 99 mTc-MIBI scan: semiquantitative analysis correlated with histologic findings. J Nucl Med 1999; 40: 1792-1797 42 Erbil Y, Kapran Y, I?sever H. et al. The positive effect of adenoma weight and oxyphil cell content on preoperative localization with 99 mTc-sestamibi scanning for primary hyperparathyroidism. Am J Surg 2008; 195: 34-39 43 Elgazzar AH, Anim JT, Dannoon SF. et al. Ultrastructure of Hyperfunctioning Parathyroid Glands: Does it Explain Various Patterns of 99 mTc-sestamibi Uptake. World J Nucl Med 2017; 16: 145-149 44 Araz M, Çayir D, Erdoğan M. et al. Factors affecting the sensitivity of Tc-99 m methoxyisobutylisonitrile dual-phase parathyroid single photon emission computed tomography in primary hyperparathyroidism. Nucl Med Commun 2017; 38: 117-123 45 Friedman K, Somervell H, Patel P. et al. Effect of calcium channel blockers on the sensitivity of preoperative 99 mTc-MIBI SPECT for hyperparathyroidism. Surgery 2004; 136: 1199-1204 46 Odparlik A, Hering AH. Lokalisationsdiagnostik von Nebenschilddrüsenadenomen mittels PET/CT. Der Nuklearmediziner 2020; 43: 244-248
